✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous
Market Cap
₹83 Cr.
P/E
9.30
  • Astal Laboratories
  • Amrapali Industries
  • Le Lavoir
FAQs on Astal Laboratories Ltd. Shareprice

Astal Laboratories has given better returns compared to its competitors.
Astal Laboratories has grown at ~52.98% over the last 3yrs while peers have grown at a median rate of 38.01%

Astal Laboratories is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Astal Laboratories is 9.3, while 3 year average PE is 111.
Also latest EV/EBITDA of Astal Laboratories is 7.4 while 3yr average is 7.38.

Growth Table
  • Astal Laboratories Ltd.
  • Amrapali Industries
  • Le Lavoir
Balance Sheet
  • Astal Laboratories Ltd.
  • Amrapali Industries
  • Le Lavoir
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Astal Laboratories Ltd.
  • Amrapali Industries
  • Le Lavoir
Cash Flow
  • Astal Laboratories Ltd.
  • Amrapali Industries
  • Le Lavoir
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Astal Laboratories Ltd.
  • Amrapali Industries
  • Le Lavoir
Quarterly Results
  • Astal Laboratories Ltd.
  • Amrapali Industries
  • Le Lavoir
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Astal Laboratories Ltd. Financials

Balance sheet of Astal Laboratories is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Astal Laboratories is increasing.
Latest net debt of Astal Laboratories is ₹11.54 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹11.84 Crs.

Yes, profit is increasing.
The profit of Astal Laboratories is ₹8.93 Crs for TTM, ₹0.78 Crs for Mar 2024 and ₹0.02 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Astal Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech